<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />

<meta name="author" content="Andrew Bean, Sebastian Weber, Lukas Widmer" />

<meta name="date" content="2021-09-01" />

<title>Guiding Oncology Dose-Escalation Trials</title>



<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
a.sourceLine { display: inline-block; line-height: 1.25; }
a.sourceLine { pointer-events: none; color: inherit; text-decoration: inherit; }
a.sourceLine:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode { white-space: pre; position: relative; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
code.sourceCode { white-space: pre-wrap; }
a.sourceLine { text-indent: -1em; padding-left: 1em; }
}
pre.numberSource a.sourceLine
  { position: relative; left: -4em; }
pre.numberSource a.sourceLine::before
  { content: attr(title);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; pointer-events: all; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {  }
@media screen {
a.sourceLine::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Guiding Oncology Dose-Escalation Trials</h1>
<h4 class="author">Andrew Bean, Sebastian Weber, Lukas Widmer</h4>
<h4 class="date">2021-09-01</h4>



<div id="introduction" class="section level2">
<h2>Introduction</h2>
<p>The <code>OncoBayes2</code> package provides flexible functions for Bayesian meta-analytic modeling of the incidence of Dose Limiting Toxicities (DLTs) by dose level, under treatment regimes involving any number of combination partners. Such models may be used to ensure patient safety during trial conduct by supporting dose-escalation decisions. In addition, the model can support estimation of the Maximum Tolerated Dose (MTD) in adaptive Bayesian dose-escalation designs.</p>
<p>Whereas traditional dose escalation designs, such as the 3+3 design, base the dosing decisions on predefined rules about the number of DLTs in the last one or two cohorts at the current dose, model-based designs such as those using Bayesian Logistic Regression Models (BLRMs) endeavor to model the dose-toxicity relationship as a continuous curve, and allow the model to guide dosing decisions. In this way, all available data contributes to the dosing decisions. Furthermore, extensions to the BLRM approach can support inclusion of available additional data on the compound(s) involved. The additional data can be either historical data collected prior trial conduct or concurrent data, which is collected during trial conduct in the context of another trial/context.</p>
<p>The package supports incorporation of additional data through a Meta-Analytic-Combined (MAC) framework [1]. Within the MAC model the hetergeneous sources of data are assigned to <em>groups</em> and information is shared accross groups through a hierarchial model structure. For any given group this leads to borrowing strength from all other groups while discounting the information from other groups. The amount of discounting (or down-weighting) is determined by the heterogeniety. A group is commonly defined to be a trial, but that must not necessarily hold.</p>
<p>The key assumption of the hierarhical model is the exchangability assumption between the groups. There are two independent mechanisms in the package which aim at relaxing the exchangability assumption:</p>
<ul>
<li><p>Differential discounting: Groups are assigned to different strata. While the overal hierarchical mean stays the same, the heterogeniety between groups is allowed to be different between strata. Each group must be assigned to a single stratum only.</p></li>
<li><p>EXchangeable/Non-EXchangeable (EX/NEX) model for each group: With EXNEX each group is modelled as being exchangable with some probability and is allowed to have it’s own group-specific estimate as if the grup is not exchangable with the remainder of the data.</p></li>
</ul>
<p>Both techniques are rather advanced and are not discussed further in this introduction.</p>
<p>In the following we illustrate first a very common use case of historical information only and then consider concurrent data in addition. In particular, we will discuss a trial evaluating a combination of two drugs whenever historical information is available on each drug individually from separate trials. This example will be expanded by using in addition concurrent data on one of the drugs and on their combination.</p>
<p><strong>Note on terminology:</strong> While in the literature (see [1], [2], and [4]) the term <em>stratum</em> refers to a trial commonly, <code>OncoBayes2</code> deviates here and uses the term <em>group</em> instead. This is more in line with hierarchical modeling terminology. The term <em>stratum</em> is used to define a higher level grouping structure. That is, every group is assigned to a single <em>stratum</em> within <code>OncoBayes2</code>. This higher level grouping (groups of groups) is necessary whenever differential discounting is used. By convention <code>OncoBayes2</code> assigns any group to the stratum “all” whenever no stratum is assigned for a group.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb1-1" title="1"><span class="co">## Load involved packages</span></a>
<a class="sourceLine" id="cb1-2" title="2"><span class="kw">library</span>(dplyr)   <span class="co">## for mutate</span></a>
<a class="sourceLine" id="cb1-3" title="3"><span class="kw">library</span>(tidyr)   <span class="co">## defines expand_grid</span></a>
<a class="sourceLine" id="cb1-4" title="4"><span class="kw">library</span>(tibble)  <span class="co">## for tibbles</span></a>
<a class="sourceLine" id="cb1-5" title="5"><span class="kw">library</span>(ggplot2) <span class="co">## for plotting</span></a></code></pre></div>
</div>
<div id="example-use-case-dual-combination-trial-with-historical-information" class="section level2">
<h2>Example use-case: Dual combination trial with historical information</h2>
<p>Consider the application described in Section 3.2 of [1], in which the risk of DLT is to be studied as a function of dose for two drugs, drug A and drug B. Historical information on the toxicity profiles of these two drugs is available from single agent trials <code>trial_A</code> and <code>trial_B</code>. The historical data for this example is available in an internal data set.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb2-1" title="1"><span class="kw">kable</span>(hist_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">33.3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">100.0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">200.0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400.0</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800.0</td>
<td align="right">20</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">1120.0</td>
<td align="right">17</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The objective is to aid dosing and dose-escalation decisions in a future trial, <code>trial_AB</code>, in which the drugs will be combined. Additionally, another investigator-initiated trial <code>IIT</code> will study the same combination concurrently. Note that these as-yet-unobserved sources of data are included in the input data as unobserved factor levels. This mechanism allows us to specify a joint meta-analytic prior for all four sources of historical and concurrent data.</p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb3-1" title="1"><span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)</a></code></pre></div>
<pre><code>## [1] &quot;trial_A&quot;  &quot;trial_B&quot;  &quot;IIT&quot;      &quot;trial_AB&quot;</code></pre>
<p>However, we will first consider only the dual combination trial AB and it’s historical data and add concurrent data at a later stage.</p>
<div id="setting-up-the-trial-design" class="section level3">
<h3>Setting up the trial design</h3>
<p>The function <code>blrm_trial</code> provides an object-oriented framework for operationalizing the dose-escalation trial design. This framework is intended as a convenient wrapper for the main model-fitting engine of the package, the <code>blrm_exnex()</code> function. The latter allows additional flexibility for specifying the functional form of the model, but <code>blrm_trial</code> covers the most common use-cases. This introductory vignette highlights <code>blrm_trial</code> in lieu of <code>blrm_exnex</code>; the reader is referred to the help-page of the function<code>?blrm_exnex</code> for more details.</p>
<p>One begins with <code>blrm_trial</code> by specifying three key design elements:</p>
<ul>
<li>The historical dose-toxicity data</li>
<li>Information about the study drugs</li>
<li>The provisional dose levels to be studied during the escalation trial</li>
</ul>
<p>Information about the study drugs is encoded through a <code>tibble</code> as below. This includes the names of the study-drugs, the reference doses (see [3] or <code>?blrm_exnex</code> to understand the role this choice plays in the model specification), the dosing units, and (optionally) the a priori expected DLT rate for each study drug given individually at the respective reference doses.</p>
<p>All design information for the study described in [1] is also included as built-in datasets, which are part of the <code>OncoBayes2</code> package.</p>
<div id="drug-info" class="section level4">
<h4>Drug info</h4>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb5-1" title="1"><span class="kw">kable</span>(drug_info_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">drug_name</th>
<th align="right">dose_ref</th>
<th align="left">dose_unit</th>
<th align="right">reference_p_dlt</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">drug_A</td>
<td align="right">6</td>
<td align="left">mg</td>
<td align="right">0.2</td>
</tr>
<tr class="even">
<td align="left">drug_B</td>
<td align="right">1500</td>
<td align="left">mg</td>
<td align="right">0.2</td>
</tr>
</tbody>
</table>
</div>
<div id="dose-info" class="section level4">
<h4>Dose info</h4>
<p>The provisional dose levels are specified as below. For conciseness, we limit the dose level of in these provisional doses.</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb6-1" title="1">dose_info &lt;-<span class="st"> </span><span class="kw">filter</span>(dose_info_combo2, group_id <span class="op">==</span><span class="st"> &quot;trial_AB&quot;</span>,</a>
<a class="sourceLine" id="cb6-2" title="2">                    drug_A <span class="op">%in%</span><span class="st"> </span><span class="kw">c</span>(<span class="dv">3</span>,<span class="dv">6</span>), drug_B <span class="op">%in%</span><span class="st"> </span><span class="kw">c</span>(<span class="dv">0</span>,<span class="dv">400</span>, <span class="dv">800</span>))</a>
<a class="sourceLine" id="cb6-3" title="3"><span class="kw">kable</span>(dose_info)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">dose_id</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">27</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">400</td>
<td align="right">28</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">800</td>
<td align="right">30</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">35</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6</td>
<td align="right">400</td>
<td align="right">36</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6</td>
<td align="right">800</td>
<td align="right">38</td>
</tr>
</tbody>
</table>
</div>
<div id="initializing-a-blrm_trial" class="section level4">
<h4>Initializing a <code>blrm_trial</code></h4>
<p>Together with the data described in the previous section, these objects can be used to initialize a <code>blrm_trial</code> object.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb7-1" title="1">combo2_trial_setup &lt;-<span class="st"> </span><span class="kw">blrm_trial</span>(</a>
<a class="sourceLine" id="cb7-2" title="2">  <span class="dt">data =</span> hist_combo2,</a>
<a class="sourceLine" id="cb7-3" title="3">  <span class="dt">drug_info =</span> drug_info_combo2,</a>
<a class="sourceLine" id="cb7-4" title="4">  <span class="dt">dose_info =</span> dose_info</a>
<a class="sourceLine" id="cb7-5" title="5">)</a></code></pre></div>
</div>
</div>
<div id="specifying-the-prior-and-fitting-the-model" class="section level3">
<h3>Specifying the prior and fitting the model</h3>
<p>At this point, the trial design has been initialized. However, in the absence of <code>simplified_prior = TRUE</code>, we have not yet specified the prior distribution for the dose-toxicity model.</p>
<p>OncoBayes2 provides two methods for completing the model specification:</p>
<ol style="list-style-type: decimal">
<li><p>Use <code>simplified_prior = TRUE</code>, which employs a package-default prior distribution, subject to a small number of optional arguments controlling the details.</p></li>
<li><p>Provide a full prior specification to be passed to the <code>blrm_exnex</code> function.</p></li>
</ol>
<p>For simplicity and concicneness purposes, here we use method #1, which is not recommended for actual trials as the prior should be choosen deliberatley and there is no gurantee that the simplified prior will remain stable accross releases of the package. See <code>?&#39;example-combo2_trial&#39;</code> for an example of #2. The below choice of prior broadly follows the case study in [4], although we slightly deviate from the model in [4] by a different reference dose and mean reference DLT rate.</p>
<p>To employ the simplified prior, and fit the model with MCMC:</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb8-1" title="1">combo2_trial_start &lt;-<span class="st"> </span><span class="kw">blrm_trial</span>(</a>
<a class="sourceLine" id="cb8-2" title="2">  <span class="dt">data =</span> hist_combo2,</a>
<a class="sourceLine" id="cb8-3" title="3">  <span class="dt">drug_info =</span> drug_info_combo2,</a>
<a class="sourceLine" id="cb8-4" title="4">  <span class="dt">dose_info =</span> dose_info,</a>
<a class="sourceLine" id="cb8-5" title="5">  <span class="dt">simplified_prior =</span> <span class="ot">TRUE</span>,</a>
<a class="sourceLine" id="cb8-6" title="6">  <span class="dt">EXNEX_comp=</span><span class="ot">FALSE</span>,</a>
<a class="sourceLine" id="cb8-7" title="7">  <span class="dt">EX_prob_comp_hist=</span><span class="dv">1</span>,</a>
<a class="sourceLine" id="cb8-8" title="8">  <span class="dt">EX_prob_comp_new=</span><span class="dv">1</span></a>
<a class="sourceLine" id="cb8-9" title="9">)</a></code></pre></div>
<p>Now, the object <code>combo2_trial_start</code> contains the posterior model fit at the start of the trial, in addition to the trial design details. Next we highlight the main methods for extracting relevant information from it.</p>
</div>
<div id="summary-of-prior-specification" class="section level3">
<h3>Summary of prior specification</h3>
<p>The function <code>prior_summary</code> provides a facility for printing, in a readable format, a summary of the prior specification.</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb9-1" title="1"><span class="kw">prior_summary</span>(combo2_trial_start) <span class="co"># not run here</span></a></code></pre></div>
</div>
<div id="summary-of-posterior" class="section level3">
<h3>Summary of posterior</h3>
<p>The main target of inference is generally the probability of DLT at a selection of provisional dose levels. To obtain these summaries for the provisional doses specified previously, we simply write:</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb10-1" title="1"><span class="kw">kable</span>(<span class="kw">summary</span>(combo2_trial_start, <span class="st">&quot;dose_prediction&quot;</span>), <span class="dt">digits =</span> <span class="dv">2</span>)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">dose_id</th>
<th align="left">stratum_id</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">prob_underdose</th>
<th align="right">prob_target</th>
<th align="right">prob_overdose</th>
<th align="left">ewoc_ok</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">27</td>
<td align="left">all</td>
<td align="right">0.06</td>
<td align="right">0.08</td>
<td align="right">0.00</td>
<td align="right">0.04</td>
<td align="right">0.26</td>
<td align="right">0.92</td>
<td align="right">0.07</td>
<td align="right">0.01</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">400</td>
<td align="right">28</td>
<td align="left">all</td>
<td align="right">0.11</td>
<td align="right">0.09</td>
<td align="right">0.01</td>
<td align="right">0.08</td>
<td align="right">0.34</td>
<td align="right">0.81</td>
<td align="right">0.17</td>
<td align="right">0.03</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">800</td>
<td align="right">30</td>
<td align="left">all</td>
<td align="right">0.18</td>
<td align="right">0.13</td>
<td align="right">0.03</td>
<td align="right">0.15</td>
<td align="right">0.54</td>
<td align="right">0.54</td>
<td align="right">0.33</td>
<td align="right">0.14</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">35</td>
<td align="left">all</td>
<td align="right">0.16</td>
<td align="right">0.11</td>
<td align="right">0.02</td>
<td align="right">0.13</td>
<td align="right">0.43</td>
<td align="right">0.59</td>
<td align="right">0.33</td>
<td align="right">0.08</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6</td>
<td align="right">400</td>
<td align="right">36</td>
<td align="left">all</td>
<td align="right">0.21</td>
<td align="right">0.15</td>
<td align="right">0.03</td>
<td align="right">0.17</td>
<td align="right">0.61</td>
<td align="right">0.47</td>
<td align="right">0.34</td>
<td align="right">0.19</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6</td>
<td align="right">800</td>
<td align="right">38</td>
<td align="left">all</td>
<td align="right">0.29</td>
<td align="right">0.21</td>
<td align="right">0.02</td>
<td align="right">0.23</td>
<td align="right">0.81</td>
<td align="right">0.36</td>
<td align="right">0.29</td>
<td align="right">0.35</td>
<td align="left">FALSE</td>
</tr>
</tbody>
</table>
<p>Such summaries may be used to assess which combination doses have unacceptable high risk of toxicity. For example, according to the escalation with overdose control (EWOC) design criteria [3], one would compute the posterior probability that each dose is excessively toxic (column <code>prob_overdose</code>; note that the definition of “excessively toxic” is encoded in the <code>blrm_trial</code> object through the <code>interval_prob</code> argument), and take as eligible doses only those where this probability does not exceed 25% (column <code>ewoc_ok</code>).</p>
</div>
<div id="posterior-predictive-summaries" class="section level3">
<h3>Posterior predictive summaries</h3>
<p>The BLRM allows a principled approach to predicting the number of DLTs that may be observed in a future cohort. This may be a key estimand for understanding and limiting the toxicity risk to patients. For example, suppose a candidate starting dose for the new trial <code>trial_AB</code> is 3 mg of drug A + 400 mg of drug B. We may wish to check that at this dose, the predictive probability of 2 or more DLTs out of an initial cohort of 3 to 6 patients is sufficiently low.</p>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb11-1" title="1">candidate_starting_dose &lt;-<span class="st"> </span><span class="kw">summary</span>(combo2_trial_start, <span class="st">&quot;dose_info&quot;</span>) <span class="op">%&gt;%</span></a>
<a class="sourceLine" id="cb11-2" title="2"><span class="st">  </span><span class="kw">filter</span>(drug_A <span class="op">==</span><span class="st"> </span><span class="dv">3</span>, drug_B <span class="op">==</span><span class="st"> </span><span class="dv">400</span>) <span class="op">%&gt;%</span></a>
<a class="sourceLine" id="cb11-3" title="3"><span class="st">  </span><span class="kw">crossing</span>(<span class="dt">num_toxicities =</span> <span class="dv">0</span>, <span class="dt">num_patients =</span> <span class="dv">3</span><span class="op">:</span><span class="dv">6</span>)</a>
<a class="sourceLine" id="cb11-4" title="4"></a>
<a class="sourceLine" id="cb11-5" title="5">pp_summary &lt;-<span class="st"> </span><span class="kw">summary</span>(combo2_trial_start, <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="op">-</span><span class="dv">1</span>, <span class="dv">0</span>, <span class="dv">1</span>, <span class="dv">6</span>), <span class="dt">predictive =</span> <span class="ot">TRUE</span>,</a>
<a class="sourceLine" id="cb11-6" title="6">                      <span class="dt">newdata =</span> candidate_starting_dose)</a>
<a class="sourceLine" id="cb11-7" title="7"></a>
<a class="sourceLine" id="cb11-8" title="8"><span class="kw">kable</span>(<span class="kw">bind_cols</span>(<span class="kw">select</span>(candidate_starting_dose, num_patients),</a>
<a class="sourceLine" id="cb11-9" title="9">                <span class="kw">select</span>(pp_summary, <span class="kw">ends_with</span>(<span class="st">&quot;]&quot;</span>))), <span class="dt">digits =</span> <span class="dv">3</span>)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="right">num_patients</th>
<th align="right">(-1,0]</th>
<th align="right">(0,1]</th>
<th align="right">(1,6]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="right">3</td>
<td align="right">0.732</td>
<td align="right">0.221</td>
<td align="right">0.048</td>
</tr>
<tr class="even">
<td align="right">4</td>
<td align="right">0.669</td>
<td align="right">0.251</td>
<td align="right">0.080</td>
</tr>
<tr class="odd">
<td align="right">5</td>
<td align="right">0.614</td>
<td align="right">0.272</td>
<td align="right">0.114</td>
</tr>
<tr class="even">
<td align="right">6</td>
<td align="right">0.567</td>
<td align="right">0.284</td>
<td align="right">0.149</td>
</tr>
</tbody>
</table>
<p>This tells us that for the initial cohort, according to the model, the chance of two or more patients developing DLTs ranges from 4.8% to 14.9%, depending on the number of patients enrolled.</p>
</div>
<div id="updating-the-model-with-new-data" class="section level3">
<h3>Updating the model with new data</h3>
<p>Dose-escalation designs are adaptive in nature, as dosing decisions are made after each sequential cohort. The model must be updated with the accrued data for each dose escalation decision point. If a new cohort of patients is observed, say:</p>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb12-1" title="1">new_cohort &lt;-<span class="st"> </span><span class="kw">tibble</span>(<span class="dt">group_id =</span> <span class="st">&quot;trial_AB&quot;</span>,</a>
<a class="sourceLine" id="cb12-2" title="2">                     <span class="dt">drug_A =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb12-3" title="3">                     <span class="dt">drug_B =</span> <span class="dv">400</span>,</a>
<a class="sourceLine" id="cb12-4" title="4">                     <span class="dt">num_patients =</span> <span class="dv">5</span>,</a>
<a class="sourceLine" id="cb12-5" title="5">                     <span class="dt">num_toxicities =</span> <span class="dv">1</span>)</a></code></pre></div>
<p>One can update the model to incorporate this new information using <code>update()</code> with <code>add_data</code> equal to the new cohort:</p>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb13-1" title="1">combo2_trial_update &lt;-<span class="st"> </span><span class="kw">update</span>(combo2_trial_start, <span class="dt">add_data =</span> new_cohort)</a></code></pre></div>
<p>This yields a new <code>blrm_trial</code> object with updated data and posterior summaries. Obtaining the summaries for the pre-planned provisional doses is then again straightforward:</p>
<div class="sourceCode" id="cb14"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb14-1" title="1"><span class="kw">kable</span>(<span class="kw">summary</span>(combo2_trial_update, <span class="st">&quot;dose_prediction&quot;</span>), <span class="dt">digits =</span> <span class="dv">2</span>)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">dose_id</th>
<th align="left">stratum_id</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">prob_underdose</th>
<th align="right">prob_target</th>
<th align="right">prob_overdose</th>
<th align="left">ewoc_ok</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">27</td>
<td align="left">all</td>
<td align="right">0.08</td>
<td align="right">0.07</td>
<td align="right">0.00</td>
<td align="right">0.06</td>
<td align="right">0.25</td>
<td align="right">0.89</td>
<td align="right">0.11</td>
<td align="right">0.01</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">400</td>
<td align="right">28</td>
<td align="left">all</td>
<td align="right">0.13</td>
<td align="right">0.08</td>
<td align="right">0.03</td>
<td align="right">0.12</td>
<td align="right">0.32</td>
<td align="right">0.70</td>
<td align="right">0.28</td>
<td align="right">0.02</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">800</td>
<td align="right">30</td>
<td align="left">all</td>
<td align="right">0.22</td>
<td align="right">0.13</td>
<td align="right">0.05</td>
<td align="right">0.19</td>
<td align="right">0.53</td>
<td align="right">0.38</td>
<td align="right">0.44</td>
<td align="right">0.18</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">35</td>
<td align="left">all</td>
<td align="right">0.18</td>
<td align="right">0.11</td>
<td align="right">0.03</td>
<td align="right">0.16</td>
<td align="right">0.45</td>
<td align="right">0.52</td>
<td align="right">0.39</td>
<td align="right">0.09</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6</td>
<td align="right">400</td>
<td align="right">36</td>
<td align="left">all</td>
<td align="right">0.24</td>
<td align="right">0.14</td>
<td align="right">0.05</td>
<td align="right">0.22</td>
<td align="right">0.58</td>
<td align="right">0.34</td>
<td align="right">0.40</td>
<td align="right">0.26</td>
<td align="left">FALSE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6</td>
<td align="right">800</td>
<td align="right">38</td>
<td align="left">all</td>
<td align="right">0.33</td>
<td align="right">0.21</td>
<td align="right">0.04</td>
<td align="right">0.30</td>
<td align="right">0.80</td>
<td align="right">0.24</td>
<td align="right">0.30</td>
<td align="right">0.46</td>
<td align="left">FALSE</td>
</tr>
</tbody>
</table>
<p>In case posterior summaries are needed for doses other than the pre-planned ones, then this is possible using the <code>newdata_prediction</code> functionality, which allows to specify a different set of doses via the <code>newdata</code> argument:</p>
<div class="sourceCode" id="cb15"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb15-1" title="1"><span class="kw">kable</span>(<span class="kw">summary</span>(combo2_trial_update, <span class="st">&quot;newdata_prediction&quot;</span>,</a>
<a class="sourceLine" id="cb15-2" title="2">              <span class="dt">newdata =</span> <span class="kw">tibble</span>(<span class="dt">group_id =</span> <span class="st">&quot;trial_AB&quot;</span>,</a>
<a class="sourceLine" id="cb15-3" title="3">                               <span class="dt">drug_A =</span> <span class="fl">4.5</span>,</a>
<a class="sourceLine" id="cb15-4" title="4">                               <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>))), <span class="dt">digits =</span> <span class="dv">2</span>)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="left">stratum_id</th>
<th align="right">dose_id</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">prob_underdose</th>
<th align="right">prob_target</th>
<th align="right">prob_overdose</th>
<th align="left">ewoc_ok</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="left">all</td>
<td align="right">NA</td>
<td align="right">0.18</td>
<td align="right">0.11</td>
<td align="right">0.04</td>
<td align="right">0.16</td>
<td align="right">0.44</td>
<td align="right">0.50</td>
<td align="right">0.41</td>
<td align="right">0.10</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="left">all</td>
<td align="right">NA</td>
<td align="right">0.23</td>
<td align="right">0.14</td>
<td align="right">0.04</td>
<td align="right">0.20</td>
<td align="right">0.56</td>
<td align="right">0.38</td>
<td align="right">0.42</td>
<td align="right">0.21</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="left">all</td>
<td align="right">NA</td>
<td align="right">0.27</td>
<td align="right">0.17</td>
<td align="right">0.05</td>
<td align="right">0.24</td>
<td align="right">0.67</td>
<td align="right">0.30</td>
<td align="right">0.38</td>
<td align="right">0.33</td>
<td align="left">FALSE</td>
</tr>
</tbody>
</table>
</div>
<div id="data-scenarios" class="section level3">
<h3>Data scenarios</h3>
<p>It may be of interest to test prospectively how this model responds in various scenarios for upcoming cohorts.</p>
<p>This can be done easily by again using <code>update()</code> with the <code>add_data</code> argument. In the code below, we explore 3 possible outcomes for a subsequent cohort enrolled at 3 mg drug A + 800 mg drug B, and review the model’s inference at adjacent doses.</p>
<div class="sourceCode" id="cb16"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb16-1" title="1"><span class="co"># set up two scenarios at the starting dose level</span></a>
<a class="sourceLine" id="cb16-2" title="2"><span class="co"># store them as data frames in a named list</span></a>
<a class="sourceLine" id="cb16-3" title="3">scenarios &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb16-4" title="4">  <span class="dt">group_id  =</span> <span class="st">&quot;trial_AB&quot;</span>,</a>
<a class="sourceLine" id="cb16-5" title="5">  <span class="dt">drug_A =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb16-6" title="6">  <span class="dt">drug_B =</span> <span class="dv">800</span>,</a>
<a class="sourceLine" id="cb16-7" title="7">  <span class="dt">num_patients =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb16-8" title="8">  <span class="dt">num_toxicities =</span> <span class="dv">0</span><span class="op">:</span><span class="dv">2</span></a>
<a class="sourceLine" id="cb16-9" title="9">) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">split</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">3</span>) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">setNames</span>(<span class="kw">paste0</span>(<span class="dv">0</span><span class="op">:</span><span class="dv">2</span>, <span class="st">&quot;/3 DLTs&quot;</span>))</a>
<a class="sourceLine" id="cb16-10" title="10"></a>
<a class="sourceLine" id="cb16-11" title="11">candidate_doses &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb16-12" title="12">  <span class="dt">group_id =</span> <span class="st">&quot;trial_AB&quot;</span>,</a>
<a class="sourceLine" id="cb16-13" title="13">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">3</span>, <span class="fl">4.5</span>),</a>
<a class="sourceLine" id="cb16-14" title="14">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb16-15" title="15">)</a>
<a class="sourceLine" id="cb16-16" title="16"></a>
<a class="sourceLine" id="cb16-17" title="17">scenario_inference &lt;-<span class="st"> </span><span class="kw">lapply</span>(scenarios, <span class="cf">function</span>(scenario_newdata) {</a>
<a class="sourceLine" id="cb16-18" title="18">  <span class="co"># refit the model with each scenario&#39;s additional data</span></a>
<a class="sourceLine" id="cb16-19" title="19">  scenario_fit &lt;-<span class="st"> </span><span class="kw">update</span>(combo2_trial_update, <span class="dt">add_data =</span> scenario_newdata)</a>
<a class="sourceLine" id="cb16-20" title="20">  <span class="co"># summarize posterior at candidate doses</span></a>
<a class="sourceLine" id="cb16-21" title="21">  <span class="kw">summary</span>(scenario_fit, <span class="st">&quot;newdata_prediction&quot;</span>, <span class="dt">newdata =</span> candidate_doses)</a>
<a class="sourceLine" id="cb16-22" title="22">}) <span class="op">%&gt;%</span></a>
<a class="sourceLine" id="cb16-23" title="23"><span class="st">  </span><span class="kw">bind_rows</span>(<span class="dt">.id=</span><span class="st">&quot;Scenario&quot;</span>)</a></code></pre></div>
<table>
<caption>Model inference for trial AB when varying hypothetical DLT scenarios for a cohort of size 3</caption>
<thead>
<tr class="header">
<th align="left">Scenario</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">prob_underdose</th>
<th align="right">prob_target</th>
<th align="right">prob_overdose</th>
<th align="left">ewoc_ok</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">0/3 DLTs</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="right">0.13</td>
<td align="right">0.08</td>
<td align="right">0.03</td>
<td align="right">0.12</td>
<td align="right">0.33</td>
<td align="right">0.70</td>
<td align="right">0.27</td>
<td align="right">0.02</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">0/3 DLTs</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">0.17</td>
<td align="right">0.10</td>
<td align="right">0.03</td>
<td align="right">0.15</td>
<td align="right">0.41</td>
<td align="right">0.55</td>
<td align="right">0.38</td>
<td align="right">0.08</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">0/3 DLTs</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="right">0.18</td>
<td align="right">0.11</td>
<td align="right">0.03</td>
<td align="right">0.15</td>
<td align="right">0.46</td>
<td align="right">0.53</td>
<td align="right">0.37</td>
<td align="right">0.10</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">0/3 DLTs</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="right">0.21</td>
<td align="right">0.14</td>
<td align="right">0.03</td>
<td align="right">0.18</td>
<td align="right">0.55</td>
<td align="right">0.43</td>
<td align="right">0.38</td>
<td align="right">0.19</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">1/3 DLTs</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="right">0.19</td>
<td align="right">0.09</td>
<td align="right">0.05</td>
<td align="right">0.17</td>
<td align="right">0.40</td>
<td align="right">0.45</td>
<td align="right">0.47</td>
<td align="right">0.08</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">1/3 DLTs</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">0.24</td>
<td align="right">0.12</td>
<td align="right">0.06</td>
<td align="right">0.22</td>
<td align="right">0.50</td>
<td align="right">0.28</td>
<td align="right">0.51</td>
<td align="right">0.22</td>
<td align="left">TRUE</td>
</tr>
<tr class="odd">
<td align="left">1/3 DLTs</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="right">0.25</td>
<td align="right">0.13</td>
<td align="right">0.05</td>
<td align="right">0.23</td>
<td align="right">0.56</td>
<td align="right">0.28</td>
<td align="right">0.46</td>
<td align="right">0.26</td>
<td align="left">FALSE</td>
</tr>
<tr class="even">
<td align="left">1/3 DLTs</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="right">0.31</td>
<td align="right">0.17</td>
<td align="right">0.06</td>
<td align="right">0.28</td>
<td align="right">0.67</td>
<td align="right">0.21</td>
<td align="right">0.39</td>
<td align="right">0.40</td>
<td align="left">FALSE</td>
</tr>
<tr class="odd">
<td align="left">2/3 DLTs</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="right">0.25</td>
<td align="right">0.11</td>
<td align="right">0.08</td>
<td align="right">0.23</td>
<td align="right">0.51</td>
<td align="right">0.22</td>
<td align="right">0.56</td>
<td align="right">0.22</td>
<td align="left">TRUE</td>
</tr>
<tr class="even">
<td align="left">2/3 DLTs</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">0.32</td>
<td align="right">0.13</td>
<td align="right">0.11</td>
<td align="right">0.31</td>
<td align="right">0.62</td>
<td align="right">0.10</td>
<td align="right">0.44</td>
<td align="right">0.45</td>
<td align="left">FALSE</td>
</tr>
<tr class="odd">
<td align="left">2/3 DLTs</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="right">0.34</td>
<td align="right">0.15</td>
<td align="right">0.10</td>
<td align="right">0.32</td>
<td align="right">0.66</td>
<td align="right">0.11</td>
<td align="right">0.42</td>
<td align="right">0.47</td>
<td align="left">FALSE</td>
</tr>
<tr class="even">
<td align="left">2/3 DLTs</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="right">0.41</td>
<td align="right">0.18</td>
<td align="right">0.12</td>
<td align="right">0.40</td>
<td align="right">0.77</td>
<td align="right">0.07</td>
<td align="right">0.28</td>
<td align="right">0.65</td>
<td align="left">FALSE</td>
</tr>
</tbody>
</table>
</div>
</div>
<div id="continuation-of-example-using-concurrent-data" class="section level2">
<h2>Continuation of example: Using concurrent data</h2>
<p>In the example of [1], at the time of completion of the first stage of <code>trial_AB</code>, the following additional data was observed.</p>
<div class="sourceCode" id="cb17"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb17-1" title="1">trial_AB_data &lt;-<span class="st"> </span><span class="kw">filter</span>(codata_combo2, group_id <span class="op">==</span><span class="st"> &quot;trial_AB&quot;</span>, cohort_time<span class="op">==</span><span class="dv">1</span>)</a>
<a class="sourceLine" id="cb17-2" title="2"><span class="kw">kable</span>(trial_AB_data)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">400</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3</td>
<td align="right">800</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6</td>
<td align="right">400</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
<p>These data are easily incorporated into the model using another call to <code>update</code>, as below.</p>
<div class="sourceCode" id="cb18"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb18-1" title="1">combo2_trial_histdata &lt;-<span class="st"> </span><span class="kw">update</span>(combo2_trial_start, <span class="dt">add_data =</span> trial_AB_data)</a></code></pre></div>
<p>However, during the first stage of <code>trial_AB</code>, the <code>trial_A</code> studying drug A did continue and collected more data on the drug A dose-toxicity relationship:</p>
<div class="sourceCode" id="cb19"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb19-1" title="1">trial_A_codata &lt;-<span class="st"> </span><span class="kw">filter</span>(codata_combo2, group_id <span class="op">==</span><span class="st"> &quot;trial_A&quot;</span>, cohort_time<span class="op">==</span><span class="dv">1</span>)</a>
<a class="sourceLine" id="cb19-2" title="2"><span class="kw">kable</span>(trial_A_codata)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0</td>
<td align="right">11</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
<p>Wthin the MAC framework we may simply add the concurrent data to our overall model which yields refined predictions for future cohorts.</p>
<div class="sourceCode" id="cb20"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb20-1" title="1">combo2_trial_codata &lt;-<span class="st"> </span><span class="kw">update</span>(combo2_trial_histdata, <span class="dt">add_data =</span> trial_A_codata)</a></code></pre></div>
<p>To compare the effect of co-data in this case it is simplest to visualize the interval probabilities as predicted by the model for the different data constellations. Here we use the function <code>plot_toxicity_intervals_stacked</code> to explore the dose-toxicity relationship in a continuous manner in terms of the dose.</p>
<div class="sourceCode" id="cb21"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb21-1" title="1"><span class="kw">plot_toxicity_intervals_stacked</span>(combo2_trial_histdata,</a>
<a class="sourceLine" id="cb21-2" title="2">                                <span class="dt">newdata=</span><span class="kw">mutate</span>(dose_info, <span class="dt">dose_id=</span><span class="ot">NULL</span>, <span class="dt">stratum_id=</span><span class="st">&quot;all&quot;</span>),</a>
<a class="sourceLine" id="cb21-3" title="3">                                <span class="dt">x =</span> <span class="kw">vars</span>(drug_B),</a>
<a class="sourceLine" id="cb21-4" title="4">                                <span class="dt">group =</span> <span class="kw">vars</span>(drug_A),</a>
<a class="sourceLine" id="cb21-5" title="5">                                <span class="dt">facet_args =</span> <span class="kw">list</span>(<span class="dt">ncol =</span> <span class="dv">1</span>)</a>
<a class="sourceLine" id="cb21-6" title="6">) <span class="op">+</span><span class="st"> </span><span class="kw">ggtitle</span>(<span class="st">&quot;Trial AB with historical data only&quot;</span>)</a></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<div class="sourceCode" id="cb22"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb22-1" title="1"><span class="kw">plot_toxicity_intervals_stacked</span>(combo2_trial_codata,</a>
<a class="sourceLine" id="cb22-2" title="2">                                <span class="dt">newdata=</span><span class="kw">mutate</span>(dose_info, <span class="dt">dose_id=</span><span class="ot">NULL</span>, <span class="dt">stratum_id=</span><span class="st">&quot;all&quot;</span>),</a>
<a class="sourceLine" id="cb22-3" title="3">                                <span class="dt">x =</span> <span class="kw">vars</span>(drug_B),</a>
<a class="sourceLine" id="cb22-4" title="4">                                <span class="dt">group =</span> <span class="kw">vars</span>(drug_A),</a>
<a class="sourceLine" id="cb22-5" title="5">                                <span class="dt">facet_args =</span> <span class="kw">list</span>(<span class="dt">ncol =</span> <span class="dv">1</span>)</a>
<a class="sourceLine" id="cb22-6" title="6">) <span class="op">+</span><span class="st"> </span><span class="kw">ggtitle</span>(<span class="st">&quot;Trial AB with historical and concurrent data on drug A&quot;</span>)</a></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<p>As we can observe, the additional data on drug A moves the maximal admissable dose allowed by EWOC towards higher doses for drug B whenever drug A is 6 mg. This reflects that drug A has been observed to be relatively safe, since no DLT was observed for a number of doses.</p>
<p>In the example of [1], during the conduct of the second satge of the <code>trial_AB</code> an additional external data source from a new trial became available. This time it is stemming from another trial which is an investigator-initiated trial <code>IIT</code> of the same combination. Numerous toxicities were observed in this concurrent study as stage 2 of <code>trial_AB</code>.</p>
<div class="sourceCode" id="cb23"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb23-1" title="1">trial_AB_stage_<span class="dv">2</span>_codata &lt;-<span class="st"> </span><span class="kw">filter</span>(codata_combo2, cohort_time<span class="op">==</span><span class="dv">2</span>)</a>
<a class="sourceLine" id="cb23-2" title="2"><span class="kw">kable</span>(trial_AB_stage_<span class="dv">2</span>_codata)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">2</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">7</td>
<td align="right">5</td>
<td align="right">2</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">2</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">400</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">2</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">600</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">2</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">2</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">2</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="right">10</td>
<td align="right">2</td>
<td align="right">2</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400</td>
<td align="right">10</td>
<td align="right">3</td>
<td align="right">2</td>
</tr>
</tbody>
</table>
<p>As before, through the MAC framework, these data can influence the model summaries for <code>trial_AB</code>. We leave it to the reader to explore the differences in the co-data (combined historical and concurrent data) vs the historical data only approach.</p>
<p>To conclude we present a graphical summary of the dose-toxicity relationship for the dual combination trial for the final data constellation. Note that we use the <code>data</code> option of <code>update</code> here to ensure that we use an entirely new dataset which includes all data collected; so this includes historical, trial and concurrent data:</p>
<div class="sourceCode" id="cb24"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb24-1" title="1">combo2_trial_final &lt;-<span class="st"> </span><span class="kw">update</span>(combo2_trial_start, <span class="dt">data =</span> codata_combo2)</a></code></pre></div>
<p>As final summary we consider the 75% quantile of the probability for a DLT at all dose combinations. Whenever the 75% quantile exceeds 33%, then the EWOC criterium is violated and the dose is too toxic.</p>
<div class="sourceCode" id="cb25"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb25-1" title="1">grid_length &lt;-<span class="st"> </span><span class="dv">25</span></a>
<a class="sourceLine" id="cb25-2" title="2"></a>
<a class="sourceLine" id="cb25-3" title="3">dose_info_plot_grid &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(<span class="dt">stratum_id =</span> <span class="st">&quot;all&quot;</span>,</a>
<a class="sourceLine" id="cb25-4" title="4">                                   <span class="dt">group_id =</span> <span class="st">&quot;trial_AB&quot;</span>,</a>
<a class="sourceLine" id="cb25-5" title="5">                                   <span class="dt">drug_A=</span><span class="kw">seq</span>(<span class="kw">min</span>(dose_info_combo2<span class="op">$</span>drug_A), <span class="kw">max</span>(dose_info_combo2<span class="op">$</span>drug_A), <span class="dt">length.out=</span>grid_length),</a>
<a class="sourceLine" id="cb25-6" title="6">                                   <span class="dt">drug_B=</span><span class="kw">seq</span>(<span class="kw">min</span>(dose_info_combo2<span class="op">$</span>drug_B), <span class="kw">max</span>(dose_info_combo2<span class="op">$</span>drug_B), <span class="dt">length.out=</span>grid_length))</a>
<a class="sourceLine" id="cb25-7" title="7"></a>
<a class="sourceLine" id="cb25-8" title="8"></a>
<a class="sourceLine" id="cb25-9" title="9">dose_info_plot_grid_sum &lt;-<span class="st"> </span><span class="kw">summary</span>(combo2_trial_final,</a>
<a class="sourceLine" id="cb25-10" title="10">                                   <span class="dt">newdata=</span>dose_info_plot_grid,</a>
<a class="sourceLine" id="cb25-11" title="11">                                   <span class="dt">prob=</span><span class="fl">0.5</span>)</a>
<a class="sourceLine" id="cb25-12" title="12"></a>
<a class="sourceLine" id="cb25-13" title="13"><span class="kw">ggplot</span>(dose_info_plot_grid_sum, <span class="kw">aes</span>(drug_A, drug_B, <span class="dt">z =</span> <span class="op">!!</span><span class="kw">as.name</span>(<span class="st">&quot;75%&quot;</span>))) <span class="op">+</span></a>
<a class="sourceLine" id="cb25-14" title="14"><span class="st">  </span><span class="kw">geom_contour_filled</span>(<span class="dt">breaks=</span><span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.1</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb25-15" title="15"><span class="st">  </span><span class="kw">scale_fill_brewer</span>(<span class="st">&quot;Quantile Range&quot;</span>, <span class="dt">type=</span><span class="st">&quot;div&quot;</span>, <span class="dt">palette =</span> <span class="st">&quot;RdBu&quot;</span>, <span class="dt">direction=</span><span class="op">-</span><span class="dv">1</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb25-16" title="16"><span class="st">  </span><span class="kw">ggtitle</span>(<span class="st">&quot;DLT Probability 75% Quantile&quot;</span>)</a></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<!---
## Advanced topics

### Grouping and stratification factors

A brief note on terminology: the `group_id` variable, present in the `data`
and `dose_info` arguments of a `blrm_trial` object, divides observations and
dose levels into homogeneous groups sharing the same set of parameters
in the hierarchical model. These `group_id`'s are referred to as "strata"
in [1], [2], and [4]. No confusion should arise between this terminology
and the `stratum_id` variable, an optional set of higher-level stratifying
factors which can serve to divide the `group_id`'s into classes which 
share the same heterogeneity parameters. For more information on models
employing multiple `stratum_id`'s, the user is referred to the
section of `?blrm_exnex` on differential discounting, and to 
`?example-combo3` for an example.
-->
</div>
<div id="references" class="section level2">
<h2>References</h2>
<p>[1] Neuenschwander, B., Roychoudhury, S., &amp; Schmidli, H. (2016). On the use of co-data in clinical trials. Statistics in Biopharmaceutical Research, 8(3), 345-354.</p>
<p>[2] Neuenschwander, B., Wandel, S., Roychoudhury, S., &amp; Bailey, S. (2016). Robust exchangeability designs for early phase clinical trials with multiple strata. Pharmaceutical statistics, 15(2), 123-134.</p>
<p>[3] Neuenschwander, B., Branson, M., &amp; Gsponer, T. (2008). Critical aspects of the Bayesian approach to phase I cancer trials. Statistics in medicine, 27(13), 2420-2439.</p>
<p>[4] Neuenschwander, B., Matano, A., Tang, Z., Roychoudhury, S., Wandel, S. Bailey, Stuart. (2014). A Bayesian Industry Approach to Phase I Combination Trials in Oncology. In Statistical methods in drug combination studies (Vol. 69). CRC Press.</p>
</div>
<div id="session-info" class="section level2">
<h2>Session Info</h2>
<div class="sourceCode" id="cb26"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb26-1" title="1"><span class="kw">sessionInfo</span>()</a></code></pre></div>
<pre><code>## R version 3.6.3 (2020-02-29)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 18.04.5 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.7.1
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.7.1
## 
## locale:
##  [1] LC_CTYPE=en_US.UTF-8       LC_NUMERIC=C              
##  [3] LC_TIME=en_US.UTF-8        LC_COLLATE=en_US.UTF-8    
##  [5] LC_MONETARY=en_US.UTF-8    LC_MESSAGES=en_US.UTF-8   
##  [7] LC_PAPER=en_US.UTF-8       LC_NAME=C                 
##  [9] LC_ADDRESS=C               LC_TELEPHONE=C            
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C       
## 
## attached base packages:
## [1] stats     graphics  grDevices utils     datasets  methods   base     
## 
## other attached packages:
## [1] ggplot2_3.3.0    tibble_3.0.0     tidyr_1.0.2      dplyr_0.8.5     
## [5] knitr_1.28       OncoBayes2_0.8-1
## 
## loaded via a namespace (and not attached):
##  [1] rstan_2.19.3       tidyselect_1.0.0   xfun_0.13          purrr_0.3.4       
##  [5] colorspace_1.4-1   vctrs_0.2.4        htmltools_0.4.0    stats4_3.6.3      
##  [9] loo_2.2.0          yaml_2.2.1         rlang_0.4.11       pkgbuild_1.0.6    
## [13] isoband_0.2.1      pillar_1.4.3       glue_1.4.0         withr_2.4.2       
## [17] RColorBrewer_1.1-2 matrixStats_0.56.0 lifecycle_0.2.0    plyr_1.8.6        
## [21] stringr_1.4.0      munsell_0.5.0      gtable_0.3.0       codetools_0.2-18  
## [25] evaluate_0.14      labeling_0.3       inline_0.3.15      callr_3.7.0       
## [29] ps_1.6.0           parallel_3.6.3     bayesplot_1.7.1    rstantools_2.1.1  
## [33] highr_0.8          Rcpp_1.0.4.6       scales_1.1.0       backports_1.1.6   
## [37] checkmate_2.0.0    RcppParallel_5.1.4 StanHeaders_2.19.2 abind_1.4-5       
## [41] farver_2.0.3       gridExtra_2.3      digest_0.6.25      stringi_1.4.6     
## [45] processx_3.5.2     grid_3.6.3         cli_2.5.0          tools_3.6.3       
## [49] magrittr_1.5       Formula_1.2-3      crayon_1.3.4       pkgconfig_2.0.3   
## [53] ellipsis_0.3.0     prettyunits_1.1.1  ggridges_0.5.2     assertthat_0.2.1  
## [57] rmarkdown_2.1      R6_2.4.1           compiler_3.6.3</code></pre>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
